Ameriprise Financial Inc Deciphera Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $47,842 - $61,159	3,523 Added 4.51%	81,688 $1.28 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $491,790 - $804,571	-48,644 Reduced 38.36%	78,165 $1.26 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $168,970 - $209,924	-13,561 Reduced 9.66%	126,809 $1.61 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $338,905 - $407,299	25,520 Added 22.22%	140,370 $1.98 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $81,880 - $126,898	-5,742 Reduced 4.76%	114,850 $1.77 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $345,173 - $442,565	-23,244 Reduced 16.16%	120,592 $1.98 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $869,930 - $1.42 Million	70,269 Added 95.52%	143,836 $2.66 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $670,195 - $1.03 Million	73,567 New	73,567 $967,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $291,984 - $427,761	-8,921 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $1.45 Million - $2.03 Million	-35,841 Reduced 80.07%	8,921 $400,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $1.02 Million - $1.31 Million	19,761 Added 79.04%	44,762 $2.56 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $1,314 - $1,744	-30 Reduced 0.12%	25,001 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $927,398 - $1.63 Million	25,031 New	25,031 $1.5 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $151,503 - $312,647	-4,505 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $142,808 - $315,034	4,505 New	4,505 $280,000
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $473,317 - $896,524	-24,807 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $142,974 - $179,303	-4,259 Reduced 14.65%	24,807 $961,000
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $583,063 - $1.31 Million	29,066 New	29,066 $1.14 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account